↓ Skip to main content

Prevalence, associations, and adequacy of treatment of major depression in patients with cancer: a cross-sectional analysis of routinely collected clinical data

Overview of attention for article published in "The Lancet Psychiatry", October 2014
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
12 news outlets
blogs
3 blogs
twitter
63 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
154 Dimensions

Readers on

mendeley
215 Mendeley
Title
Prevalence, associations, and adequacy of treatment of major depression in patients with cancer: a cross-sectional analysis of routinely collected clinical data
Published in
"The Lancet Psychiatry", October 2014
DOI 10.1016/s2215-0366(14)70313-x
Pubmed ID
Authors

Jane Walker, Christian Holm Hansen, Paul Martin, Stefan Symeonides, Ravi Ramessur, Gordon Murray, Michael Sharpe

Abstract

Major depression is an important complication of cancer. However, reliable data are lacking for the prevalence of depression in patients with cancer in different primary sites, the association of depression with demographic and clinical variables within cancer groupings, and the proportion of depressed patients with cancer receiving potentially effective treatment for depression. We investigated these questions with data from a large representative clinical sample. We analysed data from patients with breast, lung, colorectal, genitourinary, or gynaecological cancer who had participated in routine screening for depression in cancer clinics in Scotland, UK between May 12, 2008, and Aug 24, 2011. Depression screening was done in two stages (first, Hospital Anxiety and Depression Scale; then, major depression section of the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition). Data for depression status were linked with demographic and clinical data obtained from the Scottish National Cancer Registry. We analysed data for 21 151 patients. The prevalence of major depression was highest in patients with lung cancer (13·1%, 95% CI 11·9-14·2%), followed by gynaecological cancer (10·9%, 9·8-12·1), breast cancer (9·3%, 8·7-10·0), colorectal cancer (7·0%, 6·1-8·0), and genitourinary cancer (5·6%, 4·5-6·7). Within these cancer groupings, a diagnosis of major depression was more likely in patients who were younger, had worse social deprivation scores, and, for lung cancer and colorectal cancer, female patients. 1130 (73%) of 1538 patients with depression and complete patient-reported treatment data were not receiving potentially effective treatment. Major depression is common in patients attending cancer clinics and most goes untreated. A pressing need exists to improve the management of major depression for patients attending specialist cancer services. Cancer Research UK and Chief Scientist Office of the Scottish Government.

Twitter Demographics

The data shown below were collected from the profiles of 63 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 215 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 3 1%
Spain 2 <1%
Indonesia 1 <1%
Uruguay 1 <1%
Japan 1 <1%
Unknown 207 96%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 27 13%
Student > Master 27 13%
Student > Ph. D. Student 22 10%
Student > Bachelor 21 10%
Student > Postgraduate 20 9%
Other 60 28%
Unknown 38 18%
Readers by discipline Count As %
Medicine and Dentistry 73 34%
Psychology 53 25%
Nursing and Health Professions 18 8%
Agricultural and Biological Sciences 5 2%
Biochemistry, Genetics and Molecular Biology 4 2%
Other 23 11%
Unknown 39 18%

Attention Score in Context

This research output has an Altmetric Attention Score of 145. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 March 2018.
All research outputs
#148,573
of 16,606,190 outputs
Outputs from "The Lancet Psychiatry"
#213
of 1,903 outputs
Outputs of similar age
#1,808
of 203,789 outputs
Outputs of similar age from "The Lancet Psychiatry"
#3
of 68 outputs
Altmetric has tracked 16,606,190 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,903 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 81.7. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 203,789 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 68 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.